Generic Brand Classification Action Indication Contraindication Usual RATIONALE Adverse Nursing

name name Dose Effects Considerations

C C Nonsteroidal Thought to  Acute pain •Hypersensitivity to 100 to 1.Diarrhea 1.Observe
E E Anti- inhibit  Juvenile NSAIDs 200 mg 2.Nausea patient’s
L L Inflammatory prostaglandin Arthritis •Severe hepatic once or 3.Excessive 10R’s upon
E E Drugs synthesis,  Rhemautoi impairment twice a tiredness administering the
C B (NSAIDs) impending d Arthritis. •Heart failure day 4.Unusual medication.
O R cyclooxygenase •Inflammatory bleeding 2.Assess patient’s
X E – 2 to produce bowel disease or bruising ROM, degree of
I X antiinflammatory •Peptic ulcer 5.Pain in the swelling, and pain
B , •Renal impairment upper in affected joints
analgesic and •Asthma right part of before and
anti-pyretic •Urticaria the periodically
effects stomach Throughout
6.Fever therapy.
7.Swelling 3. May be
of the administered
face, throat, without regard to
tongue, lips, meals.
eyes, 4.Instruct patient
hands, feet, to take celecoxib
ankles, exactly as
or lower directed. Do not
legs take more than
8.Difficult or prescribed dose.
painful Increasing doses
urination does not appear
9.Frequent to increase
urination, effectiveness.
especially at 5.Advise patient
night to notify health
care professional
promptly
if signs or
symptoms
of GI toxicity
occurs:
6.abdominal pain
7. black stools
8. skin rash
9. unexplained
weight gain
10. edema
11. Patient should
discontinue
celecoxib
and notify health
care professional
if signs and
symptoms of
hepatotoxicity
occur:
1.Nausea
2. Fatigue
3. Lethargy
4.Flu-like
5. Instruct patient
that it
may take several
days
before he feels
consistent pain
relief
Generic Brand Classification Action Indication Contraindication Usual Rationale Adverse Effects Nursing
name name Dose Considerations

C C 2nd Inhibits cell wall 1.Infection of the 1.Hypersensitivity 250 mg q 1.Diarrhea/loo 1.Observe the
E E Generation synthesis; urinary to lower To cephalosporin 12 hour se stools patients 10R’s in
F F Cephalosporin promoting respiratory tract group of for 10 2.Nausea and administering
U T ; Antibiotic osmotic 2.Skin to skin antibiotics days vomiting medication.
R I instability; structure 2.Use cautiously 3.Abd. pain 2. Assess VS, CBC,
O N bactericidal. infection to patients with 4.Phlebitis Chemistry profile
X 3.Urinary tract hypersensitivity 5.Thrombophl 3. Assess for
I infection to penicillin. ebitis anemia,
M 4. Pharyngitis or renal dysfunction.
E tonsillitis Reduce dose with
5. Acute impaired renal
bacterial function
otitis media 4. Before the initial
6. Impetigo dose, make sure
7.Acute bacterial that has negative
exacerbations of result of skin test
chronic 5.Absorption is
bronchitis enhanced when
and secondary taken with meals
bacterial 6. Instruct the
infection patient
of acute that high fat meal
bronchitis. increases drug
bioavailability
7. If therapy is
prolonged,
monitor patient for
signs of infection
Generic Brand Classification Action Indication Contraindication Usual Rationale Adverse Effects Nursing
name name Dose Considerations

H H Corticosteroid Enters target 1. Acute 1.Hypersensitivit 100-500 1.Headache, 1.Observe the

Y Y cells hypersensitivity y to mg IM/IV insomnia, patients
D D and binds to reaction corticosteroids every 2, convulsions 10R’s in
R R cytoplasmic 2. Short-term 2.Cured or 4, or 6 psychosis administering
O O receptors; inflammatory manifest TB hours 2.Hypotensio medication.
C C initiates many and allergic 3.Renal n, shock 2.Assess VS, CBC,
O O complex disorders, such insufficiency 3.Cardiac Chemistry profile
R R reactions as rheumatoid 4.Liver disease, arrhythmias 3. Report any
T T that are arthritis, collagen cirrhosis, secondary worsening
I I responsible for diseases (SLE), hypothyroidis to electrolyte of condition, any
S S its anti- dermatologic m disturbances fever, sore throat,
O O inflammatory, diseases 5. Ulcerative 4. Thin, muscle aches, slow
N N immunosuppressi (pemphigus), colitis with fragile skin, healing, sudden
E E ve status impending petechiae, weight gain,
A (glucocorticoid), asthmaticus, and perforation striae swelling extremities
C and salt-retaining autoimmune 6.Convulsive 5. Nausea and 4.Use minimal doses
E (mineralocorticoi disorders disorders vomiting for minimal
T d) actions 3.Hematologic 7.Metastatic 6.Increased duration to
A disorders-- carcinoma appetite and minimize adverse
T thrombocytopeni 8.Diabetes weight gain effects.
E c purpura, mellitus (long-term May be taken with
erythroblastopeni therapy) food to minimize GI
a 7.Muscle upset
4. Replacement weakness 5. Patient on long
therapy in term therapy should
adrenal cortical report onset of the
insufficiency following:
6.Signs of infection
7. Hyperglycemia
8.Blurred vision
Generic Brand Classification Action Indication Contraindication Usual Rationale Adverse Effects Nursing
name name Dose Considerations

B D Stimulant Induces 1.Temporarily 1.Acute surgical 10 mg 1.Mild 1.Observe the patients

I U Laxative peristaltic relief of abdomen supposito cramping 10R’s in adm.
S L contraction by constipation 2. Nausea and ry 2.Nausea medication.
A C direct 2.For evacuation Vomiting rectally 3.Diarrhea 2. Administer in the
evening or before
C O stimulation of colon before 3. Abdominal once 4. Fluid and
breakfast because of
O L of sensory nerve surgery cramps daily electrolyte action time required
D A ending in the 3.Use to cleanse 4.Intestinal disturbances 3.Encouraged to add
Y X colonic wall. colon before obstruction (Potassium high-fiber foods to the
L delivery 5.Fecal and Calcium) regular diet
4.Relieve impaction 4. Instruct that the
constipation in 6.Use of rectal drug my cause
patient with suppository in diarrhea or
spinal cord presence of abdominal pain,
damage anal or rectal discomfort and
cramping.
fissures
5.If the suppositories
7.Appendicitis are used, it may cause
8. proctitis.
Gastroenteritis 6. Patient should
expect to have a bowel
movement within 15-
60 minutes after
administration if
Suppository is used.
It should not be
given
within 1 hour of
antacids, milk and
Milk products.
Generic Brand Classification Action Indication Contraindication Usual Rationale Adverse Effects Nursing
name name Dose Considerations

M P Analgesics, Inhibits Relief of 1.Hypersensitivity PO 500 1.Upset stomach 1.Take the

E O non-narcotic, prostaglandin moderate in aspirin, mg then and nausea medication
F N non-steroidal synthesis; pain lasting iodides, or any 250 mg 2.Heartburn with meals
E S Reduces less than 1 NSAID every 6 h 3.Dizziness Inform patient not
N T inflammatory week. 2. Preexisting as 4.drowsiness, to use drug for
A E response and renal needed. 5.Report if any of longer than 1 wk.
M L intensity of pain disease Usually the following has 2. Warn patient
I stimulus 3.Active not used Occur: about potential for
C reaching ulceration more 1. fainting bleeding.
A sensory nerve or chronic than 2.persistent/sever 3. Advise patient to
C endings. inflammation of 1 wk. e headache discontinue
I GI tract 3.hearing medication if rash
D 4.Diarrhea changes develops and to
5. Dyspepsia 4. fast/pounding contact health care
6. GI bleeding heartbeat provider.
7.Mild elevations 5. mental/mood 4.Instruct patient to
in LFT results changes report the following
5. difficult/painfu symptoms to health
l swallowing care provider:
6.swelling of the a. rash
ankles/feet/han b.visual problems
ds c. dark stools
7. sudden weight d. decreased
gain. urinary output
e. persistent
headache
or stomach pain
f. unusual bruising
or bleeding.
Advise patient to
avoid intake of
alcoholic beverages.
4.Advice patient not
to do activities that
require mental
alertness as the
drug causes
dizziness.
5. Caution patient
to avoid prolonged
exposure to
sunlight
and to use
sunscreen
or wear protective
clothing to avoid
photosensitivity
reaction.
Generic Brand Classification Action Indication Contraindication Usual Dose Rationale Adverse Effects Nursing
name name Considerations

F S Iron Iron is absorbed 1.Prevention 1.Hemosiderosis 300 to 1.Diarrhea 1.Observe

E O Preparation from the and 2.Hemochromato 325 mg 2.Stomach patient’s
R R duodenum and treatment of sis of cramps or 10R’s upon
R B upper jejunum iron 3. Peptic ulcer regularrelease upset stomach administering the
O I by active deficiency 4. Regional ferrous 3. May cause medication.
U F mechanism anemia enteritis and sulfate your stools to 2. Caution patient
S E through the 2.Dietary ulcerative orally turn black, an to make position
S R mucosal cells supplement colitis once a effect changes slowly to
U where it for iron 5. Hemolytic day. that is not minimize
L combines with anemia harmful orthostatic HPN.
F the protein 6. Pyridoxine 4. Seek 3. Advise patient
A transferring. responsive immediate to
T Iron is stored in anemia medical consult physician if
E the body as 7. Severe attention if you dyspnea, swelling
hemosiderin or hypotension notice any of of hands and feet
aggregated 8. Cirrhosis of the the following and hypotension
ferritin which is LIVER. symptoms of a occurs
found in serious allergic 4. Encourage
reticuloendothel reaction: patient to
ial cells of the a. Rash comply with
liver, spleen b. Itching additional
and bone (especially intervention for
marrow. About of the hypertension like
two thirds of face/tongue/t proper diet,
total body iron hroat) lifestyle changes &
is in the c. Severe stress mngmnt.
circulating dizziness 5. Instruct patient
RBCs in d. Trouble to avoid OTC
hemoglobin. breathing medicine
without consulting
 the physician.

Generic Brand Classification Action Indication Contraindication Usual Rationale Adverse Effects Nursing
name name Dose Considerations

A C Vitamin C Water-soluble Prevention 1.Hypersensitivity PO 150– 1.Nausea and 1.Observe patient’s

S E vitamin And treatment to any 500 mg vomiting 10R’s upon
C C essential for of component of in 1–2 2. Heartburn administering the
O O synthesis and scurvy and the preparation doses 3. Diarrhea, or medication.
R N maintenance of to acidify 2. Patients on abdominal 2. Instruct to take
B collagen and the urine sodium cramps large doses of
I intercellular restriction (high doses) vitamin C in
C ground 3. Use of calcium 4. Acute divided amounts
A substance of ascorbate in hemolytic because the body
C body tissue patients anemia uses only what is
I cells, blood receiving 5.Sickle cell needed
D vessels, digitalis. crisis at a particular time
cartilage, bones, 6. Headache or and excretes the
teeth, skin, and insomnia (high rest in urine.
tendons. Unlike doses) 3. Inform that large
most mammals, 7. Urethritis doses can interfere
humans are 8. Dysuria, with absorption of
unable to crystalluria, vitamin B12
synthesize hyperoxaluria, 4. Inform that large
ascorbic acid in or doses may cause
the body; hyperuricemia diarrhea or
therefore it (high doses) nephrolithiasis
must 9. Dizziness 5. Instruct patient
be consumed should preferably
daily. take the oral
formulation with a
 meal.

Generic Brand Classification Action Indication Contraindication Usual Rationale Adverse Effects Nursing
name name Dose Considerations

K T Non-steroidal Inhibits 1.Short term 1.Hypersensitivit 30 1.Headache 1.Observe the

E O Inflammatory prostaglandin management of y to drug mg/am 1 2. Dizziness patients
T R Agents synthesis, pain 2. Cross amp 3. Drowsiness 10R’s in
O A producing 2. Seasonal sensitivity with IVTT 4. Diarrhea administering
R D peripherally allergic other NSAIDs 5. Nausea medication.
O O mediated conjunctivitis 3. Known 6. Dyspepsia/in 2. Assess VS, CBC,
L L analgesia; 3.Inflammatory alcohol digestion Chemistry profile
A disorder of the intolerance 7. Epigastria/G 3. Patients with
C eye 4. Active peptic I pain asthma,
ulcer disease 8.Edema aspirin-induced
5. Recent GI allergy are at
bleeding or increased risk of
perforation developing
6.Advanced hypersensitivity
renal reaction
failure or in 4. Assess the
those at risk for characteristic,
renal failure location, intensity
due to volume and
depletion frequency of pain
prior to
administration
5.Instruct patient to
avoid use of alcohol,
NSAIDs, aspirin,
acetaminophen
without consulting
the physician.
6. Instruct to take
only as directed; do
not
exceed prescribed
dosage
7. Drug may cause
drowsiness and
dizziness; instruct to
avoid activities that
require mental
alertness until drug
effects.
8.Advise patient to
consult if the
following are
manifested:
1. Rash
2. Itchiness
3. Visual
disturbances
4. Tinnitus
5. Weight gain
6. Edema
7. Black stools
8. Persistent
headache
9. Effectiveness of
the therapy can be
demonstrated by
verbalization of
decreased in
severity of pain.
realized.
Generic Brand Classification Action Indication Contraindication Usual Rationale Adverse Effects Nursing
name name Dose Considerations

T H Antifibrinolytic; Synthetic 1.Epistaxis; 1.Renal Inj 0.5-1 1.Severe 1.Observe the

R E Antihemorrh derivative of the hemoptysis; function gm/kg allergic patients
A M agic amino acid hematuria impairment body reactions 10R’s in
N O lysine.It exerts it 2. Peptic ulcer 2. Hematuria of weight such as rash, administering
E S antifibrinolytic with upper urinary TID hives, medication.
X T effect through hemorrhage tract origin itching, 2. Assess VS, CBC,
A A the reversible and blood 3. Lactation dyspnea, Chemistry profile
M N blockade of dyscrasias with tightness in 3. Unusual change in
I lysinebinding hemorrhage the chest, bleeding pattern
C sites on 3. Treatment of swelling of should
A plasminogen hemorrhage the mouth, be immediately
C molecules. associated with face, lips or reported
I Antifibrinolytic excessive tongue to the physician.
D drug inhibits fibrinolysis in 2. Calf pain, 4. The medication
endometrial various swelling or can be
plasminogen surgical tenderness taken with or
activator and procedures 3. Chest pain without
thus prevents 4. Confusion meals.
fibrinolysis and 5.Coughing up 5. If you miss a dose
the breakdown blood of Tranexamic Acid,
of blood clots. 6. Decreased take it
By inhibiting the urination when you
action plasmin 7. Severe or remember,
(finronolysin) persistent then take your next
the anti- headache dose
fibrinolytic 8.Shortness of at least 6 hours
agents reduce breath later. Do
excessive not take 2 doses at
breakdown of once.
fibrin and effect 6. Inform the client
physiological that
hemostasis he/she should
inform the
physician
immediately if
the side effects
occur
Generic Brand Classification Action Indication Contraindication Usual Dose Rationale Adverse Nursing
name name Effects Considerations

M F 1.Acute infection 1. Active organic Metronidazole 1.Headache, 1.Assess pt.

E L Antibacterical with susceptible disease of the 500mg1 tab dizziness, Infection.
T A antibiotic anaerobic bacteria CNS. TID PO ataxia, 2. Watch carefully
R G 2.Acute intestinal 2.Drug Allergy peripheral for edema
O Y amoebiasis 3. Blood dyscrasia Minimum neuropathy, because it may
N L Dose: fatigue cause sodium
I PO : 250mg TID 2.Unpleasan retention
D IV : 100mg /mL t metallic 3. Assess skin for
A taste, severity areas of
Z Maximum anorexia, local adverse
O Dose: nausea, reactions.
L PO : 750 mg vomiting, 4. Record number
E TID 6-10days IV diarrhea, GI and character of
:100mg/mL upset, stools.
cramps 5. Assess pt.’s and
3.Dysuria, family’s
incontinenc knowledge of
e, darkening drug therapy.
of the urine 6. Give drug with
4.Thrombop meals to minimize
hlebitis (IV); GI distress.
redness, 7. Tablets may be
burning, crushed for pt’s.
dryness, and with difficult
skin swallowing
irritation 8. Tell pt. that
(topical) metallic taste and
dark or red brown
urine may occur.